The estimated Net Worth of Christine Z Mc Cauley is at least $1.24 Milhão dollars as of 30 November 2012. Ms Cauley owns over 11,208 units of Edwards Lifesciences Corp stock worth over $288,971 and over the last 12 years she sold EW stock worth over $954,249.
Ms has made over 1 trades of the Edwards Lifesciences Corp stock since 2012, according to the Form 4 filled with the SEC. Most recently she sold 11,208 units of EW stock worth $954,249 on 30 November 2012.
The largest trade she's ever made was selling 11,208 units of Edwards Lifesciences Corp stock on 30 November 2012 worth over $954,249. On average, Ms trades about 2,802 units every 0 days since 2012. As of 30 November 2012 she still owns at least 4,234 units of Edwards Lifesciences Corp stock.
You can see the complete history of Ms Cauley stock trades at the bottom of the page.
Christine Z. McCauley is the Corp. VP of HR at Edwards Lifesciences Corp.
Ms McCauley is 56, she's been the Corp. VP of HR of Edwards Lifesciences Corp since . There are 15 older and 5 younger executives at Edwards Lifesciences Corp. The oldest executive at Edwards Lifesciences Corp is William Link, 74, who is the Independent Director.
Christine's mailing address filed with the SEC is ONE EDWARDS WAY, , IRVINE, CA, 92614.
Over the last 21 years, insiders at Edwards Lifesciences Corp have traded over $94,964,396 worth of Edwards Lifesciences Corp stock and bought 47,398 units worth $3,992,090 . The most active insiders traders include Michael A Mussallem, Donald E Jr Bobo, eSteven R Loranger. On average, Edwards Lifesciences Corp executives and independent directors trade stock every 8 days with the average trade being worth of $1,126,057. The most recent stock trade was executed by Donald E Jr Bobo on 11 September 2024, trading 5,000 units of EW stock currently worth $226,400.
edwards lifesciences (nyse: ew) is the global leader in the science of heart valves and hemodynamic monitoring. driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. headquartered in irvine, california, edwards lifesciences has extensive operations in north america, europe, japan, latin america and asia and currently employs about 6,400 individuals worldwide. for us, helping patients is not a slogan – it's our life’s work. from developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life.
Edwards Lifesciences Corp executives and other stock owners filed with the SEC include: